Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients

Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients - Mg and BMD on fractures among HD patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043078

Enrollment

350

Registered

2021-01-21

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal failure fragility fractures

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who had undergone hemodialysis for least 2 months at Masuko Memorial Hospital

Exclusion criteria

Exclusion criteria: Patients undergoing combination therapy with peritoneal dialysis were excluded.

Design outcomes

Primary

Measure	Time frame
Any type of fragility fractures	—

Countries

Japan

Contacts

Public ContactMayuko Hori

Masuko Memorial Hospital Nephrology

m-hori@masuko.or.jp+81524511307

Outcome results